ADAG · Adagene Inc ADR
United States · RS rating 23 · As of 2026-11-03
| Price | 2.35 USD |
|---|---|
| 1-day change | +2.6% |
| RS rating (overall / 1M / 3M / 12M) | 23 / 26 / 11 / 76 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 27 / 11 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +50.8% |
| Market cap (USD) | $247.1M |